ARCHIVES

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

RFAs For New Improve Accrual Of Minorities, Women

February 2, 1996

HHS Carcinogen Guidelines Draft

June 6, 1980

Eight Years Later:In A Change of Heart, LCA Endorses NLST

April 18, 2014

NCI-Approved Clinical Trials Begun At Groups, Centers

November 30, 2007

Sen. Edward Kennedy Receives ACS Medal

January 23, 2009

HHS, MB, OSTP Urge President To Veto Biomedical Research Authorization; Senate Pushes FTE Levels

November 1, 1985